Developing Therapies that Prevent Progenitor Cell Migration for Preventing the Development and Further Growth of Endometriotic Lesions- Future Prospects-A Short Communication

In: Perceptions in Reproductive Medicine · 2020 · vol. 3(5) · doi:10.31031/prm.2020.03.000575 · W3106810245
article OA: diamond CC0
📄 Open PDF View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

This paper discusses the development of therapies to prevent progenitor cell migration as a potential strategy for treating and inhibiting the growth of endometriotic lesions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis represents a frequent as well as benign gynecological disease that is defined as the presence of endometrial tissue (glands as well as stroma) in sites external to the normal endometrium as well as rest of the parts of uterus [1]. About 10% of women of childbearing age have endometriosis with the rate escalating in recent years. There is an immediate need for getting efficacious therapies. Earlier we had reviewed on the etiopathogenesis ,management of Endometriosis as well as Adenomyosis in infertile patients ,effect on oocytes along with Endometriosis in adolescents and effectively managing both pain as well as infertility along with preventing risk of malignancy in endometriosis but still no permanent solution is coming hence the endeavor to keep looking for newer avenues [2-8].

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (15)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK